Brachial Plexus MRI for Inflammatory or Infectious Plexitis
Required Protocol at a Glance
Mandatory core sequences for this examination. Detailed rationale, conditional additions and optimisation notes are provided later in the protocol.
MRIninja Knowledge Base | Child Page — Pathology-Specific Protocol Parent page: Brachial Plexus MRI — Generic Standard Protocol Version 1.0 — August 2026
Prerequisite: This page assumes full familiarity with the Brachial Plexus MRI — Generic Standard Protocol on MRIninja, including generic sequence selection, preparation, and coronal T1/STIR baseline anatomy already covered there. Generic sequence theory, universal preparation, and standard positioning are not repeated here. This page documents exclusively what changes, what is added, and what is critically different when the clinical question is Parsonage-Turner syndrome (neuralgic amyotrophy) or other inflammatory/infectious plexitis — namely wide-field, multi-muscle-group denervation-pattern assessment, imaging-timing considerations, and the serial follow-up strategy the generic protocol does not specify.
Version 1.0 — August 2026
1. Executive Summary
1.1 Added Value over the Generic Protocol
Parsonage-Turner syndrome (neuralgic amyotrophy) is the dominant inflammatory brachial plexopathy and, together with the less common truly infectious plexitis, presents a distinct diagnostic pattern that the generic protocol’s coronal T1/STIR backbone detects reliably but does not, by itself, structure the interpretation around. This child page documents the specific semiotic pattern (nerve trunk T2 signal increase with a characteristic, often patchy denervation pattern in the affected muscle groups that frequently does not respect a single nerve root or peripheral nerve territory), the deliberate distinction from cervical radiculopathy and other mimickers, and the serial-imaging follow-up strategy the generic protocol does not specify.
1.2 Limits of the Dedicated Protocol
Parsonage-Turner syndrome remains fundamentally a clinical diagnosis, supported by a compatible imaging pattern; MRI findings, while genuinely useful, are not perfectly specific, and a normal or near-normal MRI does not exclude the diagnosis, particularly early in the disease course before denervation change has had time to develop. Distinguishing inflammatory from truly infectious plexitis on imaging alone is often not possible, and this distinction ultimately depends on clinical context (systemic infective symptoms, relevant exposure history) and, where infection is genuinely suspected, appropriate microbiological work-up rather than MRI signal characteristics alone.
2. Clinical Context
2.1 Clinical Presentation
The classic Parsonage-Turner presentation is acute-onset, severe, often nocturnal shoulder and upper arm pain, which — after a period ranging from days to a few weeks — is followed by the pain subsiding as motor weakness and, over subsequent weeks to months, muscle atrophy develop, typically in a patchy, multi-nerve distribution rather than a single classic nerve or root pattern. A preceding trigger (viral illness, vaccination, surgery, strenuous exercise) is identified in a substantial proportion of cases, though the syndrome also occurs without any identifiable antecedent event.
2.2 Inflammatory vs Infectious Distinction
The great majority of clinically encountered “brachial plexitis” is inflammatory/immune-mediated (Parsonage-Turner syndrome/neuralgic amyotrophy) rather than due to direct infectious involvement of the plexus itself; genuine infectious plexitis (direct bacterial, viral, or other pathogen involvement of the plexus, as opposed to a post-infectious immune-mediated trigger for Parsonage-Turner) is comparatively rare and typically occurs in the context of a broader, clinically apparent regional or systemic infective process (adjacent abscess, osteomyelitis, or severe systemic infection) rather than as an isolated presentation.
2.3 Differential Diagnosis (Clinical)
The acute pain phase of Parsonage-Turner syndrome is frequently, initially misattributed to a musculoskeletal shoulder problem (rotator cuff pathology, cervical radiculopathy) given the severity and location of the pain relative to the comparatively delayed onset of the more diagnostically specific motor weakness and atrophy — a diagnostic delay explicitly noted as clinically significant in the literature, underscoring the value of a compatible MRI pattern in supporting earlier recognition.
3. Indications, Timing, and Patient Selection
3.1 When the Dedicated Protocol Is Indicated
Acute severe shoulder/upper arm pain followed by motor weakness, particularly with a patchy, multi-nerve distribution not conforming to a single cervical root or peripheral nerve territory, and especially where a preceding trigger is identified, should prompt this dedicated protocol to support the clinical diagnosis and to exclude structural mimickers (mass, disc herniation with radiculopathy).
3.2 Optimal Timing
Because denervation-pattern muscle signal change (the most specific direct imaging finding) takes time to develop after nerve injury, MRI performed very early in the acute pain phase may show a normal or near-normal study despite genuine Parsonage-Turner syndrome; imaging performed once some weeks have passed, or repeated serially, substantially improves diagnostic yield for the denervation pattern central to this protocol.
3.3 Serial Imaging Strategy
Follow-up MRI at approximately 3-6 months is of genuine value both to confirm the evolving denervation-atrophy pattern supporting the diagnosis and to document the trajectory of recovery, since Parsonage-Turner syndrome’s natural history is one of gradual, though sometimes incomplete, recovery over months to years — serial imaging is not routinely required in every case but is a recognised, useful strategy when the initial presentation or imaging is ambiguous.
3.4 Red Flags Modifying Urgency
Fever, systemic signs of sepsis, or imaging evidence of an adjacent abscess or bone involvement should prompt urgent reassessment for genuine infectious plexitis or a related deep space infection, rather than the elective-timed inflammatory work-up described in the remainder of this child page.
4. Dedicated Protocol Design
4.1 Mandatory Core Sequences
The table below lists the complete mandatory protocol for inflammatory/infectious brachial plexitis — the five generic-protocol core sequences (1-5) plus the one deliberate coverage extension (6) detailed in Section 4.3. Unlike several other child protocols in this cluster, this indication does not require a genuinely new sequence type, only wider anatomical coverage of the existing core STIR sequence. See Section 4.2 for the full comparison against the generic protocol.
| # | Sequence | Plane | Status |
|---|---|---|---|
| 1 | T1-weighted TSE (bilateral, large FOV) | Coronal | Mandatory |
| 2 | STIR (bilateral, large FOV) | Coronal | Mandatory |
| 3 | T2-weighted fat-suppressed (STIR or SPAIR) | Axial | Mandatory |
| 4 | T1-weighted TSE | Axial | Mandatory |
| 5 | 3D heavily T2-weighted (CISS/DRIVE/FIESTA-C) | Coronal or axial oblique | Mandatory in modern protocol |
| 6 | Wide-field STIR (extended coverage: full shoulder girdle and proximal arm, beyond core sequences 2-3 default coverage) | Coronal/Axial | Mandatory — extended coverage |
4.2 Protocol Delta vs the Generic Brachial Plexus Protocol
| Element | Generic Protocol | Inflammatory/Infectious-Dedicated Protocol |
|---|---|---|
| Muscle signal assessment | Incidental | Deliberate, systematic review of denervation-pattern signal across multiple muscle groups, not only immediately adjacent to the plexus |
| Timing | Single study, any time | Timing relative to symptom onset explicitly considered; serial follow-up imaging a recognised strategy |
| Nerve trunk assessment | General screen | Deliberate assessment of trunk/division-level T2 signal, without an expected mass or structural correlate |
| Contrast | Conditional | Not routinely required for classic presentations; reserved for atypical cases or genuine infection concern |
4.3 Mandatory Dedicated Sequences
- Coronal and axial STIR, per the generic protocol, specifically reviewed across the full shoulder girdle and proximal arm musculature — not confined to the immediate perineural region — since the denervation pattern in Parsonage-Turner syndrome frequently involves multiple, sometimes non-contiguous muscle groups.
- Coronal T1, per the generic protocol, for baseline anatomy and, on follow-up studies, assessment of chronic denervation change (fatty muscle atrophy).
4.4 Conditional and Advanced Sequences
- Axial sequences extending further distally than the standard supraclavicular/axillary field of view may be warranted where the clinical distribution suggests involvement of individual peripheral nerves distal to the plexus itself (a recognised feature of the broader neuralgic amyotrophy spectrum, which can affect isolated peripheral nerves as well as the plexus proper).
- Post-contrast T1 fat-suppressed sequences are not routinely required for a classic presentation but should be added where a mass cannot be confidently excluded, or where genuine infectious plexitis with possible abscess or adjacent osteomyelitis is a clinical concern.
- Follow-up (3-6 month) repeat STIR/T1 to document evolving denervation pattern and support the diagnosis where the initial study was ambiguous.
4.5 Rationale per Disease-Specific Sequence
Wide-field STIR muscle assessment The rationale for deliberately extending muscle signal review beyond the immediate perineural region is that Parsonage-Turner syndrome characteristically produces a patchy, multi-nerve denervation pattern that does not respect a single root or peripheral nerve territory — a pattern only appreciated by systematically reviewing the full shoulder girdle and proximal arm musculature, not simply screening the muscles immediately adjacent to the visibly abnormal nerve trunk.
Deliberate nerve trunk T2 signal assessment without an expected structural correlate The rationale is that, unlike traumatic or neoplastic plexopathy, Parsonage-Turner syndrome’s direct nerve finding — T2 signal increase within the affected trunks/divisions — occurs without an accompanying mass, discontinuity, or other structural abnormality; recognising this “signal abnormality alone” pattern as itself diagnostically meaningful, rather than searching for a structural cause, is the specific interpretive shift this protocol requires relative to the generic protocol’s more structurally-oriented default framing.
Serial follow-up imaging The rationale for building serial imaging into the protocol design, not only as an incidental option, is that the evolving denervation-to-atrophy pattern over 3-6 months both supports the diagnosis retrospectively and provides genuinely useful prognostic information on recovery trajectory, distinct from what a single time-point study can offer.
4.6 Dedicated Planes and Field of View
The generic protocol’s coronal oblique plexus plane and axial supraclavicular/axillary coverage remain appropriate, but should be considered for extension further distally along the course of individual, clinically affected peripheral nerves when the clinical distribution suggests involvement beyond the plexus proper — a recognised feature of the broader neuralgic amyotrophy spectrum rather than an exception to it.
4.7 Contrast Strategy
Gadolinium contrast is not routinely required for a classic Parsonage-Turner presentation, since the key diagnostic findings (nerve trunk T2 signal, denervation-pattern muscle change) are non-contrast findings. Contrast should be added where a mass cannot be confidently excluded on non-contrast sequences, or where genuine infectious plexitis with possible abscess, phlegmon, or adjacent osteomyelitis is a clinical concern, using standard macrocyclic GBCA dosing and Dixon/spectral fat suppression for the post-contrast series per site-wide policy.
4.8 Sequence Matching to Clinical Question
| Clinical Question | Sequence of Primary Value |
|---|---|
| Is there a pattern supporting Parsonage-Turner syndrome? | Wide-field coronal/axial STIR, reviewing multiple muscle groups for denervation pattern |
| Is a mass genuinely excluded? | Coronal T1 (anatomical), ± post-contrast T1 if any doubt remains |
| Is genuine infection/abscess present? | Post-contrast fat-suppressed T1, added specifically when clinically suspected |
| Has the process evolved or resolved? | Follow-up STIR/T1 at 3-6 months, compared against the baseline study |
5. MRI Semiotics of Inflammatory/Infectious Plexitis
5.1 Direct Signs
T2 signal increase within the affected nerve trunks/divisions on fat-suppressed T2 or STIR sequences, without an accompanying mass, discontinuity, or other structural correlate, is the principal direct sign — a pattern of “signal change without structural cause” that itself carries diagnostic weight in the appropriate clinical context, distinct from the mass- or injury-associated signal change described in the tumour and trauma child pages.
5.2 Indirect and Secondary Signs
Denervation-pattern muscle oedema (STIR-bright, becoming fatty-atrophic on later/chronic studies) in the muscles supplied by the affected nerve trunks is the most consistently emphasised MRI finding in the reviewed literature — typically patchy and multi-focal rather than confined to a single myotome, a pattern that itself helps distinguish this condition from a single-root radiculopathy.
5.3 Severity, Extent, and Distribution Pattern
Reporting should specify which individual nerve trunks/divisions and which specific muscle groups show signal change, explicitly noting whether the distribution is patchy/multi-nerve (typical of Parsonage-Turner syndrome) or conforms instead to a single root or single peripheral nerve territory (favouring an alternative diagnosis).
5.4 Relevant Classification Frameworks
No formal MRI-specific severity or staging classification is in widespread use for Parsonage-Turner syndrome; reporting instead focuses on documenting the specific nerves/muscle groups involved and, on follow-up imaging, whether denervation change is stable, progressing, or resolving — a descriptive rather than a formally graded framework, consistent with the original clinical descriptions of the syndrome.
5.5 Differential Diagnosis on Imaging
The principal imaging differential is single-level cervical radiculopathy (a mono-radicular denervation pattern rather than the patchy, multi-nerve pattern typical of Parsonage-Turner syndrome), a discrete mass or structural lesion (excluded by the absence of a mass on the dedicated sequences in this protocol), and — where relevant clinical features are present — genuine infectious plexitis with an identifiable adjacent infective source.
5.6 Mimickers and Pitfalls
Early imaging, performed before denervation change has had time to develop, can appear normal or near-normal despite genuine Parsonage-Turner syndrome — the single most important interpretive pitfall in this protocol, and the specific reason optimal timing (Section 3.2) and, where the initial study is ambiguous, serial follow-up imaging (Section 3.3) are built into the protocol design rather than treated as optional afterthoughts.
6. Reporting Framework
6.1 Structured Reporting Template
Nerve trunks/divisions with T2 signal change: specify level(s). Distribution pattern: patchy/multi-nerve vs single-root/single-nerve. Muscle groups with denervation change: specify, and whether oedematous (acute/subacute) or fatty-atrophic (chronic). Mass excluded: explicitly stated. Comparison with prior imaging (if follow-up study): stable / progressing / improving.
6.2 Mandatory Reporting Elements
Every report should explicitly state whether the distribution pattern observed is more consistent with a diffuse, patchy, multi-nerve process (supporting Parsonage-Turner syndrome) or a single-root/single-nerve pattern (favouring an alternative diagnosis) — this distributional statement is the single most clinically useful piece of interpretive framing this protocol provides beyond a simple list of abnormal findings.
6.3 Critical/Actionable Findings
Any imaging finding suggesting a genuine mass, abscess, or other structural lesion — rather than the expected signal-only pattern of inflammatory plexitis — is a critical, actionable finding that should prompt reconsideration of the working diagnosis and appropriate further work-up, since it falls outside this child page’s expected pattern and into the tumour or infectious-complication differential instead.
6.4 Common Reporting Errors
Describing nerve trunk signal change without commenting on distribution pattern (patchy/multi-nerve vs single-root); failing to systematically review the full shoulder girdle and proximal arm musculature for denervation change beyond the immediately visualised nerve trunks; and providing a falsely reassuring “normal” report on a study performed too early in the disease course without noting this specific timing limitation.
7. Technical Pitfalls
7.1 Timing-Related False Negatives
As emphasised in Section 3.2 and Section 5.6, imaging performed very early after symptom onset carries a genuine risk of a false-negative or equivocal study, since the denervation-pattern muscle change central to this protocol’s diagnostic value has not yet had time to develop.
7.2 Sequence-Specific Technical Considerations
Because the denervation pattern in this condition is frequently patchy and can involve muscle groups outside the immediately obvious perineural field of view, technologists should ensure the standard generic-protocol coverage genuinely extends across the full shoulder girdle and proximal arm rather than being inadvertently narrowed to the plexus itself.
7.3 When the Generic Protocol Alone Is Insufficient
A brachial plexus MRI performed for suspected Parsonage-Turner syndrome using only the generic protocol’s standard, plexus-centred muscle screening, without the deliberate wide-field, multi-muscle-group review described in Section 4.3, risks under-appreciating the distributional pattern that is this protocol’s key diagnostic contribution.
8. MRI Technologist Pearls
8.1 Sequence Order Logic
No specific sequence-ordering modification beyond the generic protocol is typically required for this indication, since the diagnostic findings are read from standard coronal/axial STIR and T1 sequences rather than depending on a specialised, protocol-order-sensitive acquisition.
8.2 Positioning Tricks
Ensure coil coverage genuinely extends across the full shoulder girdle and proximal arm, not only the immediate supraclavicular plexus region, given the wide, patchy distribution of denervation change this condition can produce.
8.3 Fast Salvage Protocol
If examination time is constrained, prioritise wide-field coronal and axial STIR (the sequences carrying the denervation-pattern information central to this protocol) over additional anatomical detail sequences that add less specific diagnostic value for this particular clinical question.
8.4 Disease-Specific Common Avoidable Errors
Performing imaging too early relative to symptom onset without documenting this limitation; narrowing coverage to the plexus alone rather than the full shoulder girdle/proximal arm; and omitting an explicit statement about distribution pattern (patchy/multi-nerve vs single-root) in the report.
9. Quality Control Checklist
- Coverage confirmed to extend across the full shoulder girdle and proximal arm musculature, not only the immediate plexus region.
- Timing relative to symptom onset documented, with early-study limitations explicitly noted where relevant.
- Distribution pattern (patchy/multi-nerve vs single-root/single-nerve) explicitly assessed and stated.
- Mass explicitly excluded or, where doubt remains, addressed with post-contrast sequences.
- For follow-up studies, direct comparison with the baseline study performed and documented.
10.
Advanced Technical Parameters Specific to This Pathology
Detecting subtle, early denervation-pattern muscle signal change — particularly relevant given the timing-related false-negative risk described in Section 7.1 — benefits from careful attention to fat-suppression homogeneity across the full field of view, since the cervicothoracic and shoulder girdle region is a technically challenging B0 environment (as already established in the generic protocol’s own discussion of this issue), and inadequate fat suppression at the periphery of a wide-field acquisition can obscure genuinely subtle muscle signal change at exactly the stage of disease when imaging is most likely to be equivocal. For serial follow-up comparison specifically, using consistent sequence parameters and, where feasible, consistent scanner/field strength across the baseline and follow-up studies improves the reliability of detecting genuine interval change (progression, stability, or improvement) rather than technical variation being mistaken for a clinical change.
Bibliography for this section
11. Evidence Gaps and Ongoing Debate
- Optimal imaging timing relative to symptom onset is not fully standardised. As emphasised throughout this page, early imaging carries a genuine false-negative risk, but no single, universally agreed optimal imaging window has been established across the reviewed literature.
- Distinguishing inflammatory from truly infectious plexitis on imaging alone remains genuinely difficult, and the reviewed literature does not describe reliable imaging-based discriminating features distinct from clinical and microbiological context — Section 2.2’s distinction remains substantially a clinical, not an imaging, determination.
- The relationship between imaging severity/extent and functional recovery prognosis is incompletely characterised. While serial imaging (Section 3.3) is a recognised useful strategy, quantitative imaging-based prognostic criteria for predicting the degree or timeline of recovery remain less developed than the diagnostic semiotics themselves.
12. Evidence-Based References
A. Guidelines / Consensus / Society Recommendations
No dedicated society guideline specific to inflammatory/infectious brachial plexitis MRI protocol design was identified as warranting a separate citation for this child page, beyond the general ACR Appropriateness Criteria for brachial plexus imaging referenced on the parent master page. Category A is therefore not separately populated here.
C. Important Prospective / Original Studies
D. Technical MRI Papers
E. Landmark Historical References
End of document — Brachial Plexus MRI for Inflammatory or Infectious Plexitis — Child Protocol under the MRIninja Neck / Brachial Plexus master page — v1.0 — August 2026 Parent page: Brachial Plexus MRI — Generic Standard Protocol
Related Protocols
Recent PubMed search for this protocol